BACKGROUND: Peripherally inserted central catheters (PICC) are common venous access devices. Clinical conditions and therapies that increase the risk of PICC-associated thrombosis have not been studied. METHODS: We performed a retrospective case-control analysis of all adult patients who underwent placement of a PICC at our hospital over a three-year period (n = 1296). Clinical variables examined were indication for PICC placement, active cancer treatment, history of DVT, diabetes mellitus, and use of prophylactic anticoagulation. RESULTS: The overall incidence of PICC-associated DVT was 2% (n = 27). Active cancer therapy was significantly associated with PICC-associated DVT (OR 3.5, 95% CI 1.3-9.8). The use of prophylactic anticoagulation did not reduce this risk. CONCLUSIONS: Patients who suffered a PICC-associated DVT were more likely to be undergoing treatment for cancer. This risk was not lowered by the use of prophylactic anticoagulation. These results suggest a need for prospective studies on effective anticoagulation for patients at high risk for PICC-associated DVT.
BACKGROUND: Peripherally inserted central catheters (PICC) are common venous access devices. Clinical conditions and therapies that increase the risk of PICC-associated thrombosis have not been studied. METHODS: We performed a retrospective case-control analysis of all adult patients who underwent placement of a PICC at our hospital over a three-year period (n = 1296). Clinical variables examined were indication for PICC placement, active cancer treatment, history of DVT, diabetes mellitus, and use of prophylactic anticoagulation. RESULTS: The overall incidence of PICC-associated DVT was 2% (n = 27). Active cancer therapy was significantly associated with PICC-associated DVT (OR 3.5, 95% CI 1.3-9.8). The use of prophylactic anticoagulation did not reduce this risk. CONCLUSIONS:Patients who suffered a PICC-associated DVT were more likely to be undergoing treatment for cancer. This risk was not lowered by the use of prophylactic anticoagulation. These results suggest a need for prospective studies on effective anticoagulation for patients at high risk for PICC-associated DVT.
Authors: Sanjiv M Baxi; Emily K Shuman; Christy A Scipione; Benrong Chen; Aditi Sharma; Jennifer J K Rasanathan; Carol E Chenoweth Journal: Infect Control Hosp Epidemiol Date: 2013-06-18 Impact factor: 3.254
Authors: Jeffrey J Fletcher; Thomas J Wilson; Venkatakrishna Rajajee; William R Stetler; Teresa L Jacobs; Kyle M Sheehan; Devin L Brown Journal: Neurocrit Care Date: 2016-08 Impact factor: 3.210
Authors: Hyun Jung Kim; Jina Yun; Han Jo Kim; Kyoung Ha Kim; Se Hyung Kim; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Nam Su Lee; Kyu Taek Lee; Seong Kyu Park; Jong-Ho Won; Hee Sook Park; Dae Sik Hong Journal: J Korean Med Sci Date: 2010-11-24 Impact factor: 2.153
Authors: Sachin A Jain; Shilin N Shukla; Shailesh S Talati; Sonia K Parikh; Shivani J Bhatt; Vinayak Maka Journal: Indian J Med Paediatr Oncol Date: 2013-10